Document Detail

TNFα inhibitors restrict T cell activation and cycling via Notch-1 signalling in inflammatory bowel disease.
MedLine Citation:
PMID:  22068169     Owner:  NLM     Status:  Publisher    
BackgroundTumour necrosis factor α (TNFα) inhibitors such as adalimumab and infliximab are frequently prescribed for inflammatory bowel disease (IBD). Despite the clinical success of TNFα inhibitors, their physiological mode of action is not fully understood. The aim of this study was to investigate the mode of action of anti-TNFα agents in IBD.MethodsIt was hypothesised that Notch mediates anti-TNFα action in T cells. A study was carried out to identify Notch-1 as a link by which anti-TNFα antibodies mediate their inhibitory functions.ResultsTNFα inhibitors induced T cell apoptosis, inhibited activation, reduced cytokine secretion and restricted cell cycling. TNFα blockade at several levels showed that TNFα is responsible for inducing apoptosis by anti-TNFα but not for cell cycle restriction. By linking Notch and TNFα it was shown that (1) Notch-1 mucosal expression differs in inflamed and non-inflamed mucosa and increases in response to anti-TNFα treatment; (2) Notch-1 function is regulated by TNFα inhibitors; (3) Notch-1 binds to TNFα; and (4) Notch-1 inhibition prevents anti-TNFα-induced T cell cycle arrest but not apoptosis.ConclusionsTNFα inhibitors potently inhibit T cell function. By demonstrating for the first time that Notch-1 mediates the inhibitory effects of adalimumab and infliximab on T cell cycling, this study reveals a new mode of action and also an underlying signalling pathway by which biological agents act in IBD.
Lael Werner; Uta Berndt; Daniela Paclik; Silvio Danese; Anja Schirbel; Andreas Sturm
Related Documents :
24628689 - Zinc oxide nanoparticles impair bacterial clearance by macrophages.
22931829 - The dub-ious lack of alis in salmonella infection: a salmonella deubiquitinase regulate...
23911869 - Nucleotide receptor p2rx7 stimulation enhances lps-induced interferon-β production in ...
25138639 - The retrovirus/superantigen hypothesis of multiple sclerosis.
24178399 - How do cells optimize luminal environments of endosomes/lysosomes for efficient inflamm...
24155889 - Loss of dap12 and fcrγ drives exaggerated il-12 production and cd8(+) t cell response ...
25059229 - Cd137-inducing factors from t cells and macrophages accelerate the destabilization of a...
1436229 - Selective monocellular necrosis of hodgkin's/reed-sternberg cells and their immunoreact...
20231889 - Loss of jak2 selectively suppresses dc-mediated innate immune response and protects mic...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-7
Journal Detail:
Title:  Gut     Volume:  -     ISSN:  1468-3288     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985108R     Medline TA:  Gut     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Gastroenterology and Hepatology, Charité Campus Virchow Clinic, Universitätsmedizin Berlin, Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Flt3 ligand expands CD103? dendritic cells and FoxP3? T regulatory cells, and attenuates Crohn's-lik...
Next Document:  Increased alveolar nitric oxide and systemic inflammation markers in silica-exposed workers.